Skip to main content
. 2017 May 17;2(2):93–99. doi: 10.1016/j.ncrna.2017.05.001

Fig. 2.

Fig. 2

Cellular reprogramming for heart repair. To date reprogramming strategies as lineage conversion and/or guided differentiation from patient-specific iPSCs represent attractive strategies for the treatment of cardiovascular diseases. The possibility to work with unlimited amounts of starting cell populations (either patient fibroblasts or patient-specific iPSCs) would allow for their generation and expansion on demand.